In the latest close session, Organon (OGN) was down 1.87% at $9.46. This change lagged the S&P 500's 0.01% loss on the day. Meanwhile, the Dow lost 0.32%, and the Nasdaq, a tech-heavy index, added ...

Shares of Organon (OGN) slipped 1% to close at $6.47 on Tuesday, adding to six straight sessions of decline. The stock has fallen around 9.2% between March 2 and March 9, compared to a 1.24% decline ...

In the latest trading session, Organon (OGN) closed at $8.61, marking a +2.14% move from the previous day. The stock exceeded the S&P 500, which registered a loss of 0.53% for the day. Elsewhere, the ...

Organon (OGN) ended the recent trading session at $9.70, demonstrating a -3.39% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.37%.

We recently published a list of These 10 Firms Are On Fire Today. In this article, we are going to take a look at where Organon & Co.’s (NYSE:OGN) stands against other stocks that surged yesterday.

LOS ANGELES, June 24, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal ...

Organon (NYSE:OGN) after seventh consecutive sessions of losses, the company’s shares closed 0.78% lower at $8.95 on Wednesday. In the preceding six sessions, the company lost over 5.65%, compared to ...

Organon reports Phase 3 data showing VTAMA improved sleep in children as young as two with atopic dermatitis, reinforcing its dermatology push.